Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03281785
Other study ID # MD%2f16.12.52
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 20, 2017
Est. completion date March 1, 2019

Study information

Verified date March 2019
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Muscle weakness and dysfunction are common problems in patients hospitalized in the intensive care unit. Respiratory muscle weakness during mechanical ventilation was recognized a state of muscular fatigue. The terminology 'ventilator-induced diaphragmatic dysfunction' (VIDD) originally was introduced to describe these effects of mechanical ventilation and respiratory muscle unloading on the diaphragm.

Ultrasonography is becoming increasingly popular management of ICU patients. It is a simple, non-invasive and safe imaging technique that can be used for the assessment of distinctive diaphragmatic characteristics.

Parameters such as amplitude and velocity of contraction, which can be assessed using M-mode ultrasound. In addition, static and dynamic (thickening fraction during inspiration) diaphragmatic thickness can also be measured by ultrasonography.


Description:

The aim of this study is to evaluate the effect of different modes of mechanical ventilation on diaphragmatic thickness using ultrasonography and the relation between time of mechanical ventilation and the percentage of change of diaphragmatic thickness in head trauma patients subjected for mechanical ventilation (>2 days) intensive care unit.

Modes of ventilation will be used in the study are:

- Pressure controlled mandatory ventilation mode (P-CMV).

- Pressure synchronized intermittent mandatory ventilation mode (P-SIMV).

- Pressure support (PS) mode.


Recruitment information / eligibility

Status Completed
Enrollment 93
Est. completion date March 1, 2019
Est. primary completion date September 30, 2018
Accepts healthy volunteers No
Gender Male
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiologists (ASA) physical status grades I and II.

- Glasgow coma scale < 8.

- Selections of patients need mechanical ventilation (>2 days).

- Head trauma patients.

Exclusion Criteria:

- History of diaphragmatic disease

- Neuromuscular disease

- Anatomical malformation of the diaphragm.

- Patients with chest disease

- Diabetic patients.

- Chest trauma

- Chest malignancy.

- Use of non-invasive ventilation before the start of invasive ventilation.

- Selection of patients of short period of mechanical ventilation (< 2 days).

- Hemodynamic instability.

- Morbid obesity (body mass index > 40 kg/m2).

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Pressure controlled mandatory ventilation mode (P-CMV)
Pressure controlled mandatory ventilation mode (P-CMV)
Pressure synchronized intermittent mandatory ventilation
Pressure synchronized intermittent mandatory ventilation
Pressure support mode (PS)
Pressure support mode (PS)

Locations

Country Name City State
Egypt Mansoura University, Faculty of Medicine Mansourah DK

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diaphragmatic thickness changes in diaphragmatic thickness from baseline to nadir for 3 weeks after initiation of mechanical ventilation
Secondary The relation between time of mechanical ventilation and the percentage of change of diaphragmatic thickness measurement of the diaphragmatic thickness as usual and calculate the percentage of change of the diaphragmatic thickness over the time of mechanical ventilation for 3 weeks after initiation of mechanical ventilation
Secondary Glasgow coma scale (GCS) for 2 weeks after initiation of mechanical ventilation.
Secondary Sequential organ failure assessment (SOFA) score for 3 weeks after admission to the ICU
Secondary Complete blood picture for 3 weeks after admission to the ICU
Secondary Coagulation profile for 3 weeks after admission to the ICU
Secondary Liver function for 3 weeks after admission to the ICU
Secondary Renal function tests for 3 weeks after admission to the ICU
Secondary Mean blood pressure for 3 weeks after admission to the ICU
Secondary Heart rate for 3 weeks after admission to the ICU
Secondary Arterial Oxygen Saturation for 3 weeks after admission to the ICU
Secondary Central Venous Pressure for 3 weeks after admission to the ICU
Secondary temperature for 3 weeks after admission to the ICU
Secondary mode of ventilation for 3 weeks after initiation of mechanical ventilation
Secondary tidal volume for 3 weeks after initiation of mechanical ventilation
Secondary respiratory rate for 3 weeks after initiation of mechanical ventilation
Secondary airway pressure peak and mean airway pressure for 3 weeks after initiation of mechanical ventilation
Secondary ICU stay Time from admission to the ICU untill discharge or death for 3 weeks after initiation of mechanical ventilation
Secondary Duration of mechanical ventilation time from initiation of mechanical ventilation till extubation or death for 3 weeks after initiation of mechanical ventilation
See also
  Status Clinical Trial Phase
Completed NCT05921656 - Construction and Evaluation of Airway Leakage Risk Model of Patients With Endotracheal Tube
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Withdrawn NCT04288076 - The Brain and Lung Interaction (BALI) Study N/A
Completed NCT03031860 - Semi-quantitative Cough Strength Score (SCSS) N/A
Completed NCT02312869 - Local Assessment of Management of Burn Patients N/A
Completed NCT02545621 - A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
Completed NCT01885442 - TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients N/A
Completed NCT01204281 - Proportional Assist Ventilation (PAV) in Early Stage of Critically Ill Patients Phase 4
Terminated NCT01059929 - Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU) Phase 4
Completed NCT00824239 - Intermittent Sedation Versus Daily Interruption of Sedation in Mechanically Ventilated Patients Phase 3
Completed NCT00529347 - Mechanical Ventilation Controlled by the Electrical Activity of the Patient's Diaphragm - Effects of Changes in Ventilator Parameters on Breathing Pattern Phase 1
Unknown status NCT00260676 - Protective Ventilatory Strategy in Potential Organ Donors Phase 3
Terminated NCT00205517 - Sedation and Psychopharmacology in Critical Care N/A
Recruiting NCT04110613 - RCT: Early Feeding After PEG Placement N/A
Completed NCT04410783 - The Emergency Department Sedation Pilot Trial N/A
Recruiting NCT04821453 - NAVA vs. CMV Crossover in Severe BPD N/A
Completed NCT03930147 - Ventilation With ASV Mode in Children N/A
Recruiting NCT05029167 - REstrictive Versus LIberal Oxygen Strategy and Its Effect on Pulmonary Hypertension After Out-of-hospital Cardiac Arrest (RELIEPH-study) N/A
Recruiting NCT04849039 - Lung Microbiota and VAP Development (PULMIVAP)
Recruiting NCT06006208 - AMBU Bag Manual Ventilation vs. Transport Ventilator Mechanical Ventilation for Transport N/A